Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Smartphone allows capture of speech abnormalities associated with high risk of developing Parkinson's disease.

Rusz J, Hlavnicka J, Tykalova T, Novotny M, Dusek P, Sonka K, Ruzicka E.

IEEE Trans Neural Syst Rehabil Eng. 2018 Jun 29. doi: 10.1109/TNSRE.2018.2851787. [Epub ahead of print]

PMID:
29994713
2.

Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment.

Litwin T, Dusek P, Szafrański T, Dzieżyc K, Członkowska A, Rybakowski JK.

Ther Adv Psychopharmacol. 2018 Jul;8(7):199-211. doi: 10.1177/2045125318759461. Epub 2018 Mar 6. Review.

3.

Buccal Respiratory Chain Complexes I and IV Quantities in Huntington's Disease Patients.

Dušek P, Rodinová M, Lišková I, Klempíř J, Zeman J, Roth J, Hansíková H.

Folia Biol (Praha). 2018;64(1):31-34.

4.

Prospective memory impairment in idiopathic REM sleep behavior disorder.

Bezdicek O, Nikolai T, Nepožitek J, Peřinová P, Kemlink D, Dušek P, Příhodová I, Dostálová S, Ibarburu V, Trnka J, Kupka K, Mecková Z, Keller J, Vymazal J, Růžička E, Šonka K, Dušek P.

Clin Neuropsychol. 2018 Jul;32(5):1019-1037. doi: 10.1080/13854046.2017.1394493. Epub 2017 Oct 26.

PMID:
29072553
5.

Frontal Assessment Battery in Parkinson's Disease: Validity and Morphological Correlates.

Bezdicek O, Růžička F, Fendrych Mazancova A, Roth J, Dušek P, Mueller K, Růžička E, Jech R.

J Int Neuropsychol Soc. 2017 Sep;23(8):675-684. doi: 10.1017/S1355617717000522. Epub 2017 Jul 18.

PMID:
28716165
6.

Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.

Burgetova A, Dusek P, Vaneckova M, Horakova D, Langkammer C, Krasensky J, Sobisek L, Matras P, Masek M, Seidl Z.

AJNR Am J Neuroradiol. 2017 Jun;38(6):1079-1086. doi: 10.3174/ajnr.A5166. Epub 2017 Apr 27.

7.

Pathogenesis of Wilson disease.

Scheiber IF, Brůha R, Dušek P.

Handb Clin Neurol. 2017;142:43-55. doi: 10.1016/B978-0-444-63625-6.00005-7. Review.

PMID:
28433109
8.

Symptomatic treatment of neurologic symptoms in Wilson disease.

Litwin T, Dušek P, Członkowska A.

Handb Clin Neurol. 2017;142:211-223. doi: 10.1016/B978-0-444-63625-6.00018-5. Review.

PMID:
28433105
9.

GABA spectra and remote distractor effect in progressive supranuclear palsy: A pilot study.

Bonnet C, Rusz J, Hanuška J, Dezortová M, Jírů F, Sieger T, Jech R, Klempíř J, Roth J, Bezdíček O, Serranová T, Dušek P, Uher T, Flammand-Roze C, Hájek M, Růžička E.

Rev Neurol (Paris). 2017 Apr;173(4):225-229. doi: 10.1016/j.neurol.2017.03.007. Epub 2017 Apr 3.

PMID:
28385472
10.

Brain iron accumulation in Wilson's disease: A longitudinal imaging case study during anticopper treatment using 7.0T MRI and transcranial sonography.

Dusek P, Skoloudik D, Maskova J, Huelnhagen T, Bruha R, Zahorakova D, Niendorf T, Ruzicka E, Schneider SA, Wuerfel J.

J Magn Reson Imaging. 2018 Jan;47(1):282-285. doi: 10.1002/jmri.25702. Epub 2017 Apr 4.

PMID:
28376267
11.

Diagnostic Efficiency of Serum and Urine Procathepsin B and Cathepsin B in Patients with Carcinoma of the Urinary Bladder.

Dusek P, Kotaska K, Vesely S, Prusa R, Babjuk M.

Clin Lab. 2016 Sep 1;62(9):1709-1715. doi: 10.7754/Clin.Lab.2016.160135.

12.

Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.

Dusek P, Bahn E, Litwin T, Jabłonka-Salach K, Łuciuk A, Huelnhagen T, Madai VI, Dieringer MA, Bulska E, Knauth M, Niendorf T, Sobesky J, Paul F, Schneider SA, Czlonkowska A, Brück W, Wegner C, Wuerfel J.

Neuropathol Appl Neurobiol. 2017 Oct;43(6):514-532. doi: 10.1111/nan.12341. Epub 2016 Oct 4.

PMID:
27543917
13.

Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation.

Aaseth J, Alexander J, Bjørklund G, Hestad K, Dusek P, Roos PM, Alehagen U.

Biometals. 2016 Oct;29(5):827-39. doi: 10.1007/s10534-016-9959-8. Epub 2016 Aug 16. Review.

14.

MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T.

Sinnecker T, Schumacher S, Mueller K, Pache F, Dusek P, Harms L, Ruprecht K, Nytrova P, Chawla S, Niendorf T, Kister I, Paul F, Ge Y, Wuerfel J.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 22;3(4):e259. doi: 10.1212/NXI.0000000000000259. eCollection 2016 Aug.

15.

Transcranial Sonography of the Insula: Digitized Image Analysis of Fusion Images with Magnetic Resonance.

Školoudík D, Bártová P, Mašková J, Dušek P, Blahuta J, Langová K, Walter U, Herzig R.

Ultraschall Med. 2016 Dec;37(6):604-608. Epub 2016 Aug 3.

PMID:
27486795
16.

Comparison of transcranial sonography-magnetic resonance fusion imaging in Wilson's and early-onset Parkinson's diseases.

Mašková J, Školoudík D, Burgetová A, Fiala O, Brůha R, Záhoráková D, Serranová T, Slovák M, Ulmanová O, Růžička E, Dušek P.

Parkinsonism Relat Disord. 2016 Jul;28:87-93. doi: 10.1016/j.parkreldis.2016.04.031. Epub 2016 Apr 27.

PMID:
27147115
17.

Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.

Boublikova L, Bakardjieva-Mihaylova V, Skvarova Kramarzova K, Kuzilkova D, Dobiasova A, Fiser K, Stuchly J, Kotrova M, Buchler T, Dusek P, Grega M, Rosova B, Vernerova Z, Klezl P, Pesl M, Zachoval R, Krolupper M, Kubecova M, Stahalova V, Abrahamova J, Babjuk M, Kodet R, Trka J.

Cancer Lett. 2016 Jul 1;376(2):367-76. doi: 10.1016/j.canlet.2016.04.016. Epub 2016 Apr 13.

PMID:
27085458
18.

Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.

Schumacher S, Pache F, Bellmann-Strobl J, Behrens J, Dusek P, Harms L, Ruprecht K, Nytrova P, Chawla S, Niendorf T, Kister I, Paul F, Ge Y, Wuerfel J, Sinnecker T.

MAGMA. 2016 Jun;29(3):535-41. doi: 10.1007/s10334-016-0554-3. Epub 2016 Apr 12.

PMID:
27072685
19.

Moyamoya Vessel Pathology Imaged by Ultra-High-Field Magnetic Resonance Imaging at 7.0 T.

Dengler NF, Madai VI, Wuerfel J, von Samson-Himmelstjerna FC, Dusek P, Niendorf T, Sobesky J, Vajkoczy P.

J Stroke Cerebrovasc Dis. 2016 Jun;25(6):1544-51. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.041. Epub 2016 Apr 1.

PMID:
27053027
20.

Iron chelation in the treatment of neurodegenerative diseases.

Dusek P, Schneider SA, Aaseth J.

J Trace Elem Med Biol. 2016 Dec;38:81-92. doi: 10.1016/j.jtemb.2016.03.010. Epub 2016 Mar 24. Review.

PMID:
27033472
21.

Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.

Chawla S, Kister I, Wuerfel J, Brisset JC, Liu S, Sinnecker T, Dusek P, Haacke EM, Paul F, Ge Y.

AJNR Am J Neuroradiol. 2016 Jul;37(7):1223-30. doi: 10.3174/ajnr.A4729. Epub 2016 Mar 24.

22.

[Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data].

Šnejdrlová M, Češka R, Janíčková-Žďárská D, Honěk P, Dušek P, Pavlík T, Kvapil M.

Vnitr Lek. 2015 Nov;61(11 Suppl 3):3S30-7. Czech.

PMID:
26652963
23.

Ultrahigh-field MPRAGE Magnetic Resonance Angiography at 7.0 T in patients with cerebrovascular disease.

Madai VI, von Samson-Himmelstjerna FC, Sandow N, Weiler F, Bauer M, Vajkoczy P, Günther M, Dusek P, Von Gottberg P, Niendorf T, Wuerfel J, Sobesky J.

Eur J Radiol. 2015 Dec;84(12):2613-7. doi: 10.1016/j.ejrad.2015.09.021. Epub 2015 Oct 1.

PMID:
26462794
24.

Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?

Hoskovcová M, Dušek P, Sieger T, Brožová H, Zárubová K, Bezdíček O, Šprdlík O, Jech R, Štochl J, Roth J, Růžička E.

PLoS One. 2015 Oct 7;10(10):e0139849. doi: 10.1371/journal.pone.0139849. eCollection 2015. Erratum in: PLoS One. 2015;10(11):e0142765.

25.

Narcolepsy with cataplexy and Parkinson's disease. Case Report.

Fialová M, Dvořák P, Dušek P, Kovalská P, Šonka K.

Neuro Endocrinol Lett. 2015;36(3):226-30.

PMID:
26313387
26.

Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.

Sinnecker T, Kuchling J, Dusek P, Dörr J, Niendorf T, Paul F, Wuerfel J.

EPMA J. 2015 Aug 27;6(1):16. doi: 10.1186/s13167-015-0038-y. eCollection 2015. Review.

27.

Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.

Bozin I, Ge Y, Kuchling J, Dusek P, Chawla S, Harms L, Ruprecht K, Niendorf T, Paul F, Kister I, Sinnecker T, Wuerfel J.

PLoS One. 2015 Jul 17;10(7):e0128386. doi: 10.1371/journal.pone.0128386. eCollection 2015.

28.

Wilson disease and other neurodegenerations with metal accumulations.

Dusek P, Litwin T, Czlonkowska A.

Neurol Clin. 2015 Feb;33(1):175-204. doi: 10.1016/j.ncl.2014.09.006. Review.

PMID:
25432729
29.

The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy.

Vesely S, Jarolim L, Duskova K, Schmidt M, Dusek P, Babjuk M.

BMC Urol. 2014 Oct 2;14:79. doi: 10.1186/1471-2490-14-79.

30.

The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases.

Dusek P, Roos PM, Litwin T, Schneider SA, Flaten TP, Aaseth J.

J Trace Elem Med Biol. 2015;31:193-203. doi: 10.1016/j.jtemb.2014.05.007. Epub 2014 Jun 2. Review.

PMID:
24954801
31.

Grooved pegboard predicates more of cognitive than motor involvement in Parkinson's disease.

Bezdicek O, Nikolai T, Hoskovcová M, Štochl J, Brožová H, Dušek P, Zárubová K, Jech R, Růžička E.

Assessment. 2014 Dec;21(6):723-30. doi: 10.1177/1073191114524271. Epub 2014 Mar 3.

PMID:
24590077
32.

Imaging of iron.

Dusek P, Dezortova M, Wuerfel J.

Int Rev Neurobiol. 2013;110:195-239. doi: 10.1016/B978-0-12-410502-7.00010-7. Review.

PMID:
24209440
33.

Neurodegenerative disorder with brain iron accumulation previously known as SENDA syndrome now genetically determined.

Dusek P, Schneider SA.

Mov Disord. 2013 Jul;28(8):1051-2. doi: 10.1002/mds.25424. Epub 2013 Jul 18. No abstract available.

PMID:
23868373
34.

Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA).

Schneider SA, Dusek P, Hardy J, Westenberger A, Jankovic J, Bhatia KP.

Curr Neuropharmacol. 2013 Jan;11(1):59-79. doi: 10.2174/157015913804999469.

35.

Sex, food and threat: startling changes after subthalamic stimulation in Parkinson's disease.

Serranová T, Sieger T, Dušek P, Růžička F, Urgošík D, Růžička E, Valls-Solé J, Jech R.

Brain Stimul. 2013 Sep;6(5):740-5. doi: 10.1016/j.brs.2013.03.009. Epub 2013 Apr 6.

PMID:
23602024
36.

The subthalamic microlesion story in Parkinson's disease: electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in fMRI.

Jech R, Mueller K, Urgošík D, Sieger T, Holiga Š, Růžička F, Dušek P, Havránková P, Vymazal J, Růžička E.

PLoS One. 2012;7(11):e49056. doi: 10.1371/journal.pone.0049056. Epub 2012 Nov 7.

37.

Positron emission tomography and clinical predictors of survival in primary extragonadal germ cell tumors.

Buchler T, Dusek P, Brisuda A, Simonova K, Fencl P, Jarkovsky J, Babjuk M, Abrahamova J.

Klin Onkol. 2012;25(3):178-83.

PMID:
22724566
38.

Neurodegeneration with brain iron accumulation.

Dusek P, Schneider SA.

Curr Opin Neurol. 2012 Aug;25(4):499-506. doi: 10.1097/WCO.0b013e3283550cac. Review.

PMID:
22691760
39.

Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome.

Vesely S, Jarolim L, Schmidt M, Minarik I, Dusek P, Babjuk M.

World J Urol. 2013 Apr;31(2):299-304. doi: 10.1007/s00345-012-0892-3. Epub 2012 Jun 10.

PMID:
22684375
40.

Urine and serum cathepsin B concentrations in the transitional cell carcinoma of the bladder.

Kotaska K, Dusek P, Prusa R, Vesely S, Babjuk M.

J Clin Lab Anal. 2012 Feb;26(2):61-5. doi: 10.1002/jcla.21483.

PMID:
22467319
41.

Iron dysregulation in movement disorders.

Dusek P, Jankovic J, Le W.

Neurobiol Dis. 2012 Apr;46(1):1-18. doi: 10.1016/j.nbd.2011.12.054. Epub 2012 Jan 12. Review.

PMID:
22266337
42.

Abnormal activity in the precuneus during time perception in Parkinson's disease: an fMRI study.

Dušek P, Jech R, Sieger T, Vymazal J, Růžička E, Wackermann J, Mueller K.

PLoS One. 2012;7(1):e29635. doi: 10.1371/journal.pone.0029635. Epub 2012 Jan 6.

43.

Theta-burst transcranial magnetic stimulation over the supplementary motor area decreases variability of temporal estimates.

Dusek P, Jech R, Havrankova P, Vymazal J, Wackermann J.

Neuro Endocrinol Lett. 2011;32(4):481-6.

PMID:
21876488
44.

Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease.

Serranová T, Jech R, Dušek P, Sieger T, Růžička F, Urgošík D, Růžička E.

Mov Disord. 2011 Oct;26(12):2260-6. doi: 10.1002/mds.23880. Epub 2011 Jul 20.

PMID:
21780183
45.

Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease.

Dusek P, Busková J, Růzicka E, Majerová V, Srp A, Jech R, Roth J, Sonka K.

Clin Neuropharmacol. 2010 Jul;33(4):186-90. doi: 10.1097/WNF.0b013e3181e71166.

PMID:
20661025
46.

Repetitive TMS of the somatosensory cortex improves writer's cramp and enhances cortical activity.

Havrankova P, Jech R, Walker ND, Operto G, Tauchmanova J, Vymazal J, Dusek P, Hromcik M, Ruzicka E.

Neuro Endocrinol Lett. 2010;31(1):73-86.

PMID:
20150883
47.

Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.

Kawaciuk I, Hyrsl L, Dusek P, Jarolim L, Schmidt M, Kaliska V, Chocholaty M, Vesely S.

Scand J Urol Nephrol. 2008;42(5):406-11. doi: 10.1080/00365590802022151.

PMID:
18932106
48.

Increase in body weight is a non-motor side effect of deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

Novakova L, Ruzicka E, Jech R, Serranova T, Dusek P, Urgosik D.

Neuro Endocrinol Lett. 2007 Feb;28(1):21-5.

PMID:
17277730
49.

Deep brain stimulation of the subthalamic nucleus affects resting EEG and visual evoked potentials in Parkinson's disease.

Jech R, Růzicka E, Urgosík D, Serranová T, Volfová M, Nováková O, Roth J, Dusek P, Mecír P.

Clin Neurophysiol. 2006 May;117(5):1017-28. Epub 2006 Mar 3.

PMID:
16516544
50.

[Time perception in functional brain imaging].

Jech R, Dusek P, Wackermann J, Vymazal J.

Cas Lek Cesk. 2005;144(10):678-84. Czech.

PMID:
16279433

Supplemental Content

Support Center